148 related articles for article (PubMed ID: 34933332)
1. Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report.
Balas N; Hageman L; Wu J; Francisco L; Schlichting E; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2022 Apr; 6(8):2471-2479. PubMed ID: 34933332
[TBL] [Abstract][Full Text] [Related]
2. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
McDonald AM; Chen Y; Wu J; Hageman L; Francisco L; Kung M; Wong FL; Ness E; Landier W; Battles K; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
J Clin Oncol; 2020 Sep; 38(25):2872-2882. PubMed ID: 32673169
[TBL] [Abstract][Full Text] [Related]
3. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
4. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
5. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report.
Johnston EE; Meng Q; Hageman L; Wu J; Ross E; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Armenian SH; Weisdorf DJ; Landier W; Bhatia S
Blood Adv; 2023 Jun; 7(12):2843-2854. PubMed ID: 36724527
[TBL] [Abstract][Full Text] [Related]
6. Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Oliver MM; Meng Q; Hageman L; Landier W; Balas N; Ross E; Francisco L; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2024 Mar; 130(5):803-815. PubMed ID: 37880912
[TBL] [Abstract][Full Text] [Related]
7. Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.
Farrukh N; Hageman L; Chen Y; Wu J; Ness E; Kung M; Francisco L; Parman M; Landier W; Arora M; Armenian S; Bhatia S; Williams GR
Cancer; 2020 Jan; 126(9):2003-2012. PubMed ID: 32022263
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Battles K; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2261-2266. PubMed ID: 31278995
[TBL] [Abstract][Full Text] [Related]
9. Nonmyeloablative conditioning regimens and bone marrow transplantation--some contemporary aspects.
Gocheva LB
Folia Med (Plovdiv); 2010; 52(1):12-7. PubMed ID: 20380282
[TBL] [Abstract][Full Text] [Related]
10. Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.
Brunstein CG; DeFor TE; Fuchs EJ; Karanes C; McGuirk JP; Rezvani AR; Eapen M; O'Donnell PV; Weisdorf DJ;
Transplant Cell Ther; 2021 Oct; 27(10):879.e1-879.e3. PubMed ID: 34273598
[TBL] [Abstract][Full Text] [Related]
11. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
12. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS report.
Holmqvist AS; Meng Q; Dai C; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas N; Bosworth A; Te HS; Bhatia R; Rosenthal J; Wong FL; Weisdorf D; Armenian SH; Bhatia S
Leukemia; 2024 Mar; 38(3):601-609. PubMed ID: 38374408
[TBL] [Abstract][Full Text] [Related]
13. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
[TBL] [Abstract][Full Text] [Related]
14. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
[TBL] [Abstract][Full Text] [Related]
15. Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality.
Balas N; Richman JS; Landier W; Shrestha S; Bruxvoort KJ; Hageman L; Meng Q; Ross E; Bosworth A; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Leukemia; 2024 Apr; ():. PubMed ID: 38580835
[TBL] [Abstract][Full Text] [Related]
16. Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study.
Melin J; Tiitinen A; Hirvonen E; Malila N; Pitkäniemi J; Gissler M; Madanat-Harjuoja L
Hum Reprod; 2021 Nov; 36(12):3131-3140. PubMed ID: 34491339
[TBL] [Abstract][Full Text] [Related]
17. Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report.
Bhatia S; Dai C; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Arora M; Armenian SH; Weisdorf DJ; Landier W
J Clin Oncol; 2023 Feb; 41(5):1011-1022. PubMed ID: 36455192
[TBL] [Abstract][Full Text] [Related]
18. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study.
Arora M; Chen Y; Wu J; Hageman L; Ness E; Kung M; Francisco L; Bosworth A; Weisdorf DJ; Forman SJ; Landier W; Pamukçuoğlu M; Armenian SH; Wong FL; Bhatia S
Cancer; 2021 Mar; 127(5):794-800. PubMed ID: 33206383
[TBL] [Abstract][Full Text] [Related]
20. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
